Skip to main content
SpringerLink
Log in

Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry

  • Letter to the Editor
  • Published:
Forensic Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. The International Federation for Equestrian Sports (2018) The FEI equine prohibited substances database. http://prohibitedsubstancesdatabase.feicleansport.org/search. Accessed 6 Aug 2018

  2. The United States Pharmacopeial Convention (2008) Corticosteroids—glucocorticoid effects (veterinary-systemic). https://cdn.ymaws.com/www.aavpt.org/resource/resmgr/imported/corticosteroids2008.pdf. Accessed 6 Aug 2018

  3. Gibson T, Burry HC, Poswillo D, Glass J (1977) Effect of intra-articular corticosteroid injections on primate cartilage. Ann Rheum Dis 36:74–79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Evans NA (2004) Current concepts in anabolic-androgenic steroids. Am J Sports Med 32:534–542

    Article  PubMed  Google Scholar 

  5. Kuhn CM (2002) Anabolic steroids. Recent Prog Horm Res 57:411–434

    Article  CAS  PubMed  Google Scholar 

  6. Craig CR, Stitzel RE (2004) Modern pharmacology with clinical applications, 6th edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  7. Godwin M, Dawes M (2004) Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician 50:241–248

    PubMed  PubMed Central  Google Scholar 

  8. Breyer J, Jacobson HR (1990) Molecular mechanisms of diuretic agents. Annu Rev Med 41:265–275

    Article  CAS  PubMed  Google Scholar 

  9. Brater DC (1983) Pharmacodynamic considerations in the use of diuretics. Annu Rev Pharmacol Toxicol 23:45–62

    Article  CAS  PubMed  Google Scholar 

  10. Goyal RK, Hirano I (1996) Mechanisms of disease: the enteric nervous system. N Engl J Med 334:1106–1115

    Article  CAS  PubMed  Google Scholar 

  11. Majewski H (1983) Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J Auton Pharmacol 3:47–60

    Article  CAS  PubMed  Google Scholar 

  12. Davis E, Loiacono R, Summers RJ (2009) The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br J Pharmacol 154:584–597

    Article  CAS  Google Scholar 

  13. Franchimont P, Gaspard U, Reuter A, Heynen G (1972) Polymorphism of protein and polypeptide hormones. Clin Endocrinol 4:315–336

    Article  Google Scholar 

  14. Ali I, Gupta VK, Aboul-Enein HY, Singh P, Sharma B (2007) Role of racemization in optically active drugs development. Chirality 19:453–463

    Article  CAS  PubMed  Google Scholar 

  15. Adams J (1993) Structure–activity and dose–response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol 15:193–202

    Article  CAS  PubMed  Google Scholar 

  16. Agranat I, Caner H, Caldwell J (2002) Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1:753–768

    Article  CAS  PubMed  Google Scholar 

  17. Andrews JE, Ebron-McCoy M, Bojic U, Nau H, Kavlock RJ (1995) Validation of an in vitro teratology system using chiral substances: stereo selective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol Appl Pharmacol 132:310–316

    Article  CAS  PubMed  Google Scholar 

  18. Anonymous (1997) Fenfluramine and dexfenfluramine withdrawn from market. Am J Health Syst Pharm 54:2260–2269

    Google Scholar 

  19. Oh SS, Hess O (2015) Chiral metamaterials: enhancement and control of optical activity and circular dichroism. Nano Converg 2:24. https://doi.org/10.1186/s40580-015-0058-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Cahn RS, Ingold C, Prelog V (1956) The specification of asymmetric configuration in organic chemistry. Experientia 12:81–94

    Article  CAS  Google Scholar 

  21. Smith SW (2009) Chiral toxicology: it’s the same thing…only different. Toxicol Sci 110:4–30

    Article  CAS  PubMed  Google Scholar 

  22. Tripathi K (1993) Drug enantiomers and their pharmacological implications. Ind J Pharmacol 25:73–77

    CAS  Google Scholar 

  23. Porter WH (1991) Resolution of chiral drugs. Pure Appl Chem 63:1119–1122

    Article  CAS  Google Scholar 

  24. Burke D, Henderson DJ (2002) Chirality: a blueprint for the future. Br J Anaesth 88:563–576

    Article  CAS  PubMed  Google Scholar 

  25. Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26:663–668

    Article  CAS  PubMed  Google Scholar 

  26. Ribeiro C, Santos C, Gonçalves V, Ramos A, Afonso C, Tiritan ME (2018) Chiral drug analysis in forensic chemistry: an overview. Molecules 23:262. https://doi.org/10.3390/molecules23020262

    Article  CAS  PubMed Central  Google Scholar 

  27. Taschwer M, Grascher J, Schmid MG (2016) Development of an enantioseparation method for novel psychoactive drugs by HPLC using a Lux® Cellulose-2 column in polar organic phase mode. Forensic Sci Int 270:232–240

    Article  CAS  PubMed  Google Scholar 

  28. Hegstad S, Havnen H, Helland A, Spigset O, Frost J (2018) Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry. J Chromatogr B 1077-1078:7–12

    Article  CAS  Google Scholar 

  29. Doi T, Tagami T, Takeda A, Asada A, Sawabe Y (2018) Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers. Forensic Toxicol 36:51–60

    Article  CAS  PubMed  Google Scholar 

  30. Karatt TK, Nalakath J, Perwad Z, Albert PH, Khader KKA, Padusha MSA, Laya S (2018) Mass spectrometric method for distinguishing isomers of dexamethasone via fragment mass ratio: an HRMS approach. J Mass Spectrom 53:1046–1058

    Article  CAS  PubMed  Google Scholar 

  31. Peng L, Jayapalan S, Chankvetadze B, Farkas T (2010) Reversed-phase chiral HPLC and LC/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. J Chromatogr A 1217:6942–6955

    Article  CAS  PubMed  Google Scholar 

  32. Tachibana K, Ohnishi A (2001) Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases. J Chromatogr A 906:127–154

    Article  CAS  PubMed  Google Scholar 

  33. Karatt TK, Sayed R, Nalakath J, Perwad Z, Albert PH, Abdul Khader KK (2018) Separation and identification of the epimeric doping agents—dexamethasone and betamethasone in equine urine and plasma: a reversed phase chiral chromatographic approach. Steroids 140:77–82

    Article  CAS  PubMed  Google Scholar 

  34. Barhate CL, Wahab MF, Breitbach ZS, Bell DS, Armstrong DW (2015) High efficiency, narrow particle size distribution, sub-2 μm based macrocyclic glycopeptide chiral stationary phases in HPLC and SFC. Anal Chim Acta 898:128–137

    Article  CAS  PubMed  Google Scholar 

  35. Dolzan MD, Shu Y, Smuts JP, Petersen H, Ellegaard P, Micke GA, Armstrong DW, Breitbach ZS (2016) Enantiomeric separation of citalopram analogues by HPLC using macrocyclic glycopeptide and cyclodextrin based chiral stationary phases. J Liq Chromatogr Relat Technol 39:154–160

    Article  CAS  Google Scholar 

  36. Kosel M, Eap CB, Amey M, Baumann P (1998) Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J Chromatogr B 719:234–238

    Article  CAS  Google Scholar 

  37. Matthijs N, Perrin C, Maftouh M, Massart DL, Vander Heyden Y (2004) Definition and system implementation of strategies for method development of chiral separations in normal-or reversed-phase liquid chromatography using polysaccharide-based stationary phases. J Chromatogr A 1041:119–133

    Article  CAS  PubMed  Google Scholar 

  38. Padivitage NL, Dodbiba E, Breitbach ZS, Armstrong DW (2014) Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases. Drug Test Anal 6:542–551

    Article  CAS  PubMed  Google Scholar 

  39. Geryk R, Kalíková K, Vozka J, Tesarˇová E (2013) Immobilized polysaccharide-based stationary phases for enantioseparation in normal versus reversed phase HPLC. Chromatographia 76:483–489

    Article  CAS  Google Scholar 

  40. USP (1978) The United States Pharmacopeia, 20th revision. The United States Pharmacopeia, Washington, DC, p 943

    Google Scholar 

  41. Perrin C, Vu VA, Matthijs N, Maftouh M, Massart DL, Vander Heyden Y (2002) Screening approach for chiral separation of pharmaceuticals: Part I. Normal-phase liquid chromatography. J Chromatogr A 947:69–83

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are thankful to Dr. Ali Ridha, Director General, (Central Veterinary Research Laboratory) for the valuable suggestions and support. We acknowledge the support and assistance of the Equine Forensic Unit management and staff in this project.

Author information

Authors and Affiliations

  1. Equine Forensic Unit, Central Veterinary Research Laboratory, PO Box 597, Dubai, United Arab Emirates

    Tajudheen K. Karatt, Abdul Khader Karakka Kal, Ramy Sayed, Jahfar Nalakath & Zubair Perwad

Authors
  1. Tajudheen K. Karatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdul Khader Karakka Kal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ramy Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jahfar Nalakath
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zubair Perwad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdul Khader Karakka Kal.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karatt, T.K., Kal, A.K.K., Sayed, R. et al. Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry. Forensic Toxicol 37, 254–260 (2019). https://doi.org/10.1007/s11419-018-0453-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11419-018-0453-6

Search

Navigation